Sastasundar Ventures Limited (IN:SASTASUNDR)
:SASTASUNDR
Want to see IN:SASTASUNDR full AI Analyst Report?
SASTASUNDR Stock Chart & Stats
₹311.85
-₹1.25(-0.39%)
At close: 4:00 PM EST
₹311.85
-₹1.25(-0.39%)
Day’s Range― - ―
52-Week Range₹241.50 - ₹375.00
Previous CloseN/A
Volume8.84K
Average Volume (3M)4.89K
Market Cap
₹8.84B
Enterprise Value₹8.80B
Total Cash (Recent Filing)₹240.06M
Total Debt (Recent Filing)₹51.49M
Price to Earnings (P/E)207.7
Beta0.76
Next Earnings
May 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding31,810,500
10 Day Avg. Volume1,551
30 Day Avg. Volume4,895
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.20
Price to Sales (P/S)0.74
P/FCF Ratio-29.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-17.6
Revenue Forecast (FY)₹33.40B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Equity BaseThe company's low leverage and substantial equity provide durable financial flexibility. Minimal debt reduces interest burdens and makes it easier to absorb operating volatility, support working capital needs, and pursue strategic investment or restructuring without immediate financing pressure.
Prior Revenue Growth MomentumHistorical revenue growth between 2023 and 2024 indicates the business has shown capacity to expand sales. That prior momentum suggests underlying demand and execution potential which, if sustained or rebuilt, supports medium-term recovery of scale economics and improved unit margins.
Healthcare Platform And Distribution FocusOperating consumer-facing healthcare and fulfilment platforms taps into structurally steady pharmaceutical demand and recurring product flows. Platform and distribution capabilities can create durable customer relationships, recurring revenue streams and differentiation versus single-channel players.
Bears Say
Revenue Decline And Recurring LossesSustained revenue contraction alongside recurring net losses undermines scale economics and long-term profitability. Falling top-line reduces ability to invest in growth or absorb fixed costs, heightening the risk that losses persist absent successful strategic remediation.
Weak Cash GenerationNegative operating cash flow and sharply lower free cash flow indicate the business is not converting sales into sustainable liquidity. This imposes reliance on external financing for operations or growth and constrains flexibility for capex, working capital and strategic investments over the medium term.
Persistent Margin And Efficiency IssuesNegative operating and EBITDA margins point to structural inefficiencies in cost base or revenue mix. Without margin recovery, scaling revenue will not translate into profitability, limiting return on equity and making it harder to justify reinvestment absent clear cost or model changes.
Sastasundar Ventures Limited News
SASTASUNDR FAQ
What was Sastasundar Ventures Limited’s price range in the past 12 months?
Sastasundar Ventures Limited lowest stock price was ₹241.50 and its highest was ₹375.00 in the past 12 months.
What is Sastasundar Ventures Limited’s market cap?
Sastasundar Ventures Limited’s market cap is ₹8.84B.
When is Sastasundar Ventures Limited’s upcoming earnings report date?
Sastasundar Ventures Limited’s upcoming earnings report date is May 28, 2026 which is in 24 days.
How were Sastasundar Ventures Limited’s earnings last quarter?
Sastasundar Ventures Limited released its earnings results on Feb 06, 2026. The company reported ₹0.355 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.355.
Is Sastasundar Ventures Limited overvalued?
According to Wall Street analysts Sastasundar Ventures Limited’s price is currently Overvalued.
Does Sastasundar Ventures Limited pay dividends?
Sastasundar Ventures Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of N/A. See more information on Sastasundar Ventures Limited dividends here
What is Sastasundar Ventures Limited’s EPS estimate?
Sastasundar Ventures Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sastasundar Ventures Limited have?
Sastasundar Ventures Limited has 31,810,500 shares outstanding.
What happened to Sastasundar Ventures Limited’s price movement after its last earnings report?
Sastasundar Ventures Limited reported an EPS of ₹0.355 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.017%.
Which hedge fund is a major shareholder of Sastasundar Ventures Limited?
Currently, no hedge funds are holding shares in IN:SASTASUNDR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sastasundar Ventures Limited
Sastasundar Ventures Limited operates a digital network of healthcare in India. It finances loans, and invests in shares and securities, as well as provides financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The company also operates sastasundar.com and retailershakti.com portal for pathology and healthcare products marketing activities, as well as provides diagnostic services, such as pathological/radiological investigations. In addition, it distributes medicines and wellness products; and provides customized heath supplements and diet counselling, as well as health information services. The company was formerly known as Microsec Financial Services Limited and changed its name to Sastasundar Ventures Limited in November 2016. Sastasundar Ventures Limited was incorporated in 1989 and is based in Kolkata, India.